- Home
- NKSH vs FENC Comparison
NKSH vs FENC Comparison
Compare NKSH & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NKSH
- FENC
- Stock Information
- Founded
- NKSH 1891
- FENC 1996
- Country
- NKSH United States
- FENC United States
- Employees
- NKSH N/A
- FENC N/A
- Industry
- NKSH Major Banks
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NKSH Finance
- FENC Health Care
- Exchange
- NKSH Nasdaq
- FENC Nasdaq
- Market Cap
- NKSH 185.4M
- FENC 156.9M
- IPO Year
- NKSH N/A
- FENC 2001
- Fundamental
- Price
- NKSH $30.25
- FENC $5.74
- Analyst Decision
- NKSH Strong Buy
- FENC Strong Buy
- Analyst Count
- NKSH 1
- FENC 2
- Target Price
- NKSH $38.00
- FENC $14.00
- AVG Volume (30 Days)
- NKSH 14.2K
- FENC 68.3K
- Earning Date
- NKSH 10-24-2024
- FENC 11-07-2024
- Dividend Yield
- NKSH 5.18%
- FENC N/A
- EPS Growth
- NKSH N/A
- FENC N/A
- EPS
- NKSH 1.44
- FENC N/A
- Revenue
- NKSH $43,450,000.00
- FENC $49,348,000.00
- Revenue This Year
- NKSH N/A
- FENC $170.43
- Revenue Next Year
- NKSH $19.72
- FENC $6.70
- P/E Ratio
- NKSH $20.17
- FENC N/A
- Revenue Growth
- NKSH N/A
- FENC 278.09
- 52 Week Low
- NKSH $26.00
- FENC $3.96
- 52 Week High
- NKSH $35.00
- FENC $11.49
- Technical
- Relative Strength Index (RSI)
- NKSH 56.69
- FENC 46.75
- Support Level
- NKSH $26.00
- FENC $5.47
- Resistance Level
- NKSH $29.66
- FENC $6.19
- Average True Range (ATR)
- NKSH 1.02
- FENC 0.25
- MACD
- NKSH 0.29
- FENC -0.09
- Stochastic Oscillator
- NKSH 90.81
- FENC 24.77
About NKSH National Bankshares Inc.
National Bankshares Inc is a bank holding company. It focuses on lending to small and mid-sized businesses and individuals. The types of loans it offers include commercial and agricultural, commercial real estate, construction for commercial and residential properties, residential real estate, home equity, and various consumer loan products. It also operates an insurance and brokerage subsidiary, National Bankshares Financial Services, Inc. The company earns its revenues from interest and fees on loans, non-interest income, and investments.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.